Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and EfficacySally C. M. Lau, Adrian G. Sacher, Andrew Hope et al.|JTO Clinical and Research Reports|2021Cited by 11